若年性関節リウマチ:世界の治験レビュー(2017年下半期版)

◆英語タイトル:Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2017
◆商品コード:GDHC4684CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年10月31日
◆ページ数:78
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界における若年性関節リウマチ治療の臨床試験動向について調査・分析し、アジア/ヨーロッパ/アメリカ/中南米の主要国における治験件数、フェーズ別の治験件数、進捗状況別の治験件数、有望なスポンサー、有望な薬剤、治験関連の最新ニュース、主要企業分析、主要な治験プロファイル分析などの情報をご提供致します。
・若年性関節リウマチ:主要地域別治験動向
・若年性関節リウマチ:アジア市場
・若年性関節リウマチ:ヨーロッパ市場
・若年性関節リウマチ:アメリカ市場
・若年性関節リウマチ:中南米市場
・若年性関節リウマチ:中東・アフリカ市場
・若年性関節リウマチ:段階(フェーズ)別治験件数
・若年性関節リウマチ:進捗状況別の治験件数
・若年性関節リウマチ:スポンサーの種類別治験件数
・若年性関節リウマチ:有望なスポンサー
・若年性関節リウマチ:有望な薬剤分析
・若年性関節リウマチ:主要企業分析
【レポートの概要】

Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Juvenile Rheumatoid Arthritis Global Clinical Trials Review, H2, 2017″ provides an overview of Juvenile Rheumatoid Arthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Juvenile Rheumatoid Arthritis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
-
- Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Juvenile Rheumatoid Arthritis to Immunology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Juvenile Rheumatoid Arthritis to Immunology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Juvenile Rheumatoid Arthritis 30
Nov 02, 2017: Bristol-Myers Squibb to Showcase Company’s Progress in Researching Personalized Medicine for the Potential Treatment of Autoimmune Diseases at 2017 American College of Rheumatology and Association of Rheumatology Health Professionals Annual Meeting 30
Clinical Trial Profile Snapshots 32
Appendix 76
Abbreviations 76
Definitions 76
Research Methodology 77
Secondary Research 77
About GlobalData 78
Contact Us 78
Source 78

List of Tables
Juvenile Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Region, 2017* 7
Juvenile Rheumatoid Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Juvenile Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14
Proportion of Juvenile Rheumatoid Arthritis to Immunology Clinical Trials, G7 Countries (%), 2017* 15
Juvenile Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Juvenile Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Juvenile Rheumatoid Arthritis to Immunology Clinical Trials, E7 Countries (%), 2017* 18
Juvenile Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Juvenile Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Juvenile Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Phase, 2017* 21
Juvenile Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
Juvenile Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Juvenile Rheumatoid Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 26
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29

List of Figures
Juvenile Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Juvenile Rheumatoid Arthritis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Juvenile Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14
Proportion of Juvenile Rheumatoid Arthritis to Immunology Clinical Trials, G7 Countries (%), 2017* 15
Juvenile Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
Juvenile Rheumatoid Arthritis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
Proportion of Juvenile Rheumatoid Arthritis to Immunology Clinical Trials, E7 Countries (%), 2017* 18
Juvenile Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 19
Juvenile Rheumatoid Arthritis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 20
Juvenile Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
Juvenile Rheumatoid Arthritis Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
Juvenile Rheumatoid Arthritis Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Global, by End Point Status, 2017* 24
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 25
Juvenile Rheumatoid Arthritis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 26
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 27
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 28
Juvenile Rheumatoid Arthritis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 29
GlobalData Methodology 77

【掲載企業】

Pfizer Inc
C. H. Boehringer Sohn AG & Co KG
Amgen Inc
Mylan NV
Parexel International Corp
Novartis AG
Johnson & Johnson
Bristol-Myers Squibb Co
AbbVie Inc
Abbott Laboratories

【レポートのキーワード】

若年性関節リウマチ、治験、臨床試験、治療薬

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[若年性関節リウマチ:世界の治験レビュー(2017年下半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆